Pediatric rheumatology

Ovarian dysfunction in adolescent girls with autoimmune rheumatic diseases

Pediatr Rheumatol Online JPublished Retrospective cohort study

Authors' conclusion

Menstrual abnormalities is a common disturbance among adolescent girls with ARDs. The SLICC/ACR damage index is the main determinant for menstrual abnormalities rather than the cumulative steroid use or disease duration in JSLE.

Study context

Population
Adolescent girls aged 13–18 years with juvenile idiopathic arthritis (JIA), juvenile systemic lupus erythematosus (JSLE) or juvenile dermatomyositis (JDM) classified by international classification criteria
Participants
21 / 23 / 8
Exposure
Menstrual abnormalities across JIA, JSLE and JDM; regular vs abnormal cycles within each disease
  • JSLEn = 21
  • JIAn = 23
  • JDMn = 8
Outcome
Menstrual and pubertal abnormalities
Methodological detailsdata collected from patients' files, logistic regression, Puberty and menstruation assessed by a gynaecologist with US evaluation
  • Data collected from patients' files
  • Logistic regression
  • Puberty and menstruation assessed by a gynaecologist with US evaluation

Main finding

As reported in the abstract

Menstrual abnormalities

Observational data: associations, not effects.

Further findings

Predictors of menstrual abnormalities in JSLE (abnormal vs regular cycles)

Median SLICC/ACR DI statistically higher in JSLE with abnormal menstrual cycles
Cumulative steroid dose and puberty onset likewise higher
SLICC/ACR DI the most significant predictor of menstrual abnormalities in JSLE

JIA and JDM subgroups (abnormal vs regular cycles)

No difference in disease parameters, hormonal profile, US assessment or treatment lines

Original publication

Ovarian dysfunction in adolescent girls with autoimmune rheumatic diseases. Pediatr Rheumatol Online J. Published 14 November 2023. doi:10.1186/s12969-023-00923-7

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.